SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-19-040592
Filing Date
2019-07-16
Accepted
2019-07-16 17:31:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a19-12888_1sc13da.htm SC 13D/A 44685
  Complete submission text file 0001104659-19-040592.txt   46333
Mailing Address 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94107
Business Address
Machado Patrick (Filed by) CIK: 0001311210 (see all company filings)

Type: SC 13D/A

Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708
Axovant Gene Therapies Ltd. (Subject) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-88883 | Film No.: 19957817
SIC: 2834 Pharmaceutical Preparations